KMT2D and prostate adenocarcinoma: To further investigate whether KMT2D regulates AR protein levels via G3BP1 and the underlying mechanism, we first analyzed transcriptomic data from TCGA-PRAD and observed a positive correlation between KMT2D and G3BP1 expression (Fig. 3a).